Viewing Study NCT05241860

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:03 AM
Ignite Modification Date: 2026-01-28 @ 9:59 AM
Study NCT ID: NCT05241860
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-22
First Post: 2022-01-31
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Testing Interruption of Hormonal Medications in Patients Responding Exceptionally to Therapy for Metastatic Prostate Cancer, (A-DREAM)
Sponsor: Alliance for Clinical Trials in Oncology
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Castration-Sensitive Prostate Carcinoma View
None Metastatic Prostate Carcinoma View
None Stage IV Prostate Cancer AJCC v8 View
None Stage IVA Prostate Cancer AJCC v8 View
None Stage IVB Prostate Cancer AJCC v8 View
Keywords: